Side Effects And Antibody Response - PubMed
Maybe your like
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- Publication types
- MeSH terms
- Substances
- LinkOut - more resources
Abstract
The immune response after vaccination with a plasma-derived hepatitis B unit vaccine (MSD) administered intradermally or subcutaneously in 2 microgram doses was compared to the recommended 20 microgram dose administered intramuscularly. The trial was performed in 58 healthy volunteers 20-43 (mean 30) years old. No statistically significant difference in seroconversion rate was observed when the intradermal (i.d.) (2 micrograms) and intramuscular (i.m.) (20 micrograms) routes were compared (100% and 96% seroconversion, respectively). The 2 microgram dose administered subcutaneously gave a seroconversion rate of only 63%. The intradermal and i.m. routes also gave significantly higher mean titers of anti-HBs than the subcutaneous route (p less than 0.005). No severe reactions occurred and local reactions were seen almost exclusively in those vaccinated intradermally. These reactions included mainly discoloration, itching and nodule formation at the site of injection. The intradermal route ought to be considered for administration of hepatitis B vaccine since the dosage can be reduced to 1/10 without affecting the antibody response. Correct intradermal deposition of the vaccine is, however, crucial for an adequate immune response. This is probably the main disadvantage if large-scale vaccination programs should be carried out in developing countries using i.d. immunization.
PubMed Disclaimer
Publication types
- Clinical Trial Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Comparative Study Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Randomized Controlled Trial Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Research Support, Non-U.S. Gov't Actions
- Search in PubMed
- Search in MeSH
- Add to Search
MeSH terms
- Adult Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Antibody Formation Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Hepatitis B / prevention & control* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Hepatitis B Antibodies / analysis Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Injections, Intradermal Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Injections, Intramuscular Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Injections, Subcutaneous Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Male Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Viral Hepatitis Vaccines / administration & dosage* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Viral Hepatitis Vaccines / adverse effects Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- Hepatitis B Antibodies Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Viral Hepatitis Vaccines Actions
- Search in PubMed
- Search in MeSH
- Add to Search
LinkOut - more resources
Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
- Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Tag » Where Is Hepatitis B Vaccine Administered
-
Vaccine Schedules - Hepatitis B Foundation
-
Hepatitis B Vaccination
-
Hepatitis B Vaccine - HealthHub
-
Hepatitis B - Vaccination Of Adults | CDC
-
Hepatitis B Vaccine (Intramuscular Route) Proper Use - Mayo Clinic
-
Hepatitis B Vaccination - An Overview | ScienceDirect Topics
-
Hepatitis B Vaccination For Adults — Who Needs It And When?
-
[PDF] Standing Orders For Administering Hepatitis B Vaccine To Adults
-
HEPATITIS B VACCINE - MSF Medical Guidelines
-
Recommended Doses Of Hepatitis B Vaccine
-
Hepatitis B Vaccine - Infections - MSD Manual Consumer Version
-
Hepatitis B Vaccine
-
Hepatitis B Vaccine With Consultation | Raffles Health Singapore